ClinicalTrials.gov
public full text
Public Domain
The Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)
This study evaluate the Smart System of Disease Management（SSDM）to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be randomized in the SSDM group and the control group. The patients in the SSDM group will use the SSDM every month and the control group will receive the conventional therapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Artrite reumatóide como modelo de imunossenescência prematura#946253
- Harnessing patient health data to benefit individuals and advance research: a focus on rheumatoid arthritis - a narrative review.#678454
- An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA#902856
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)#1172807
- An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis#865940
Record · ID 862007
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive